Book on hepatitis from page 545 to another book
545
P
p7 protein 91
Partial Response 204
Pathogenesis
hepatitis D 178
Pegasys 137, 205
PEG‐IFN lambda 1 256
PEG‐IFN maintenance therapy 215
PEG‐Intron 205
Pegylated interferon alpha 182
Peliosis hepatis 513
Penicillamine 443, 444
Pentoxifylline 496
Perinatal transmission
hepatitis B virus 34
hepatitis C virus 46
Peripheral neuropathy 273, 275
treatment 278
PF‐00868554 240
Phlebotomy 418
PHX1766 239
Polyarteritis nodosa 41
Porphyria cutanea tarda 273
Portal vein thrombosis 518
Postexposure prophylaxis
hepatitis B infection 36
PPI‐461 240, 251
Prednisone 458
Pregnancy‐induced liver injury 530
Primary biliary cirrhosis 467
Primary sclerosing cholangitis 473
Prognosis
hepatitis B 39
Prophylaxis
viral hepatitis 108
PSI‐7977 250
PSI‐938 240, 250
Psychosis 262
Q
Quadruple therapy 254
Qualitative assays for HCV RNA detection
192
Qualitative RT‐PCR 192
Quantitative HCV RNA detection 193
R
R1626 240
R7128 240
R7227 239
Radiotherapy 344
Raltegravir 308
Rapamycin 462
Rapid Virological Response 204
RealTimeHCV test 196
Real‐time PCR technology 197
Real‐time PCR‐based HCV RNA detection
assays 194
Rebetol 205
Recombinant interferon alpha
delta hepatitis 182
Relapse 204
Renal impairment 275
Reverse hybridising assay 197
Rheumatoid arthralgias 273
Rheumatoid factor positivity 273
ribavirin 306
Ribavirin 181, 205, 223, 322
Rifampicin 470
Roferon 137, 205
RVR 204
S
SCH503034 239
SCH900518 239
Sebivo 137
Serotonin antagonists 470
Serum HBV DNA assays 121
Sexual impotence 417
Sexual transmission
hepatitis B virus 33
hepatitis C virus 46
Sicca syndrome 273
Side effects 262
management 221
Simeprevir 239
Sinusoidal obstruction syndrome 509
Skin disorders 267
Sleep disturbances 262, 266
Sorafenib 344
Suicidal syndrome 262
Sulindac 472
Sustained Virological Response 204
SVR 204
SVR‐12 204
Systemic vasculitis 275
treatment 278
546
T
Tacrolimus 462, 464
Taxonomy
hepatitis C virus 86
TDF 138
Telaprevir 205, 210, 239, 244, 253, 308
adverse effects 268
Telbivudine 137, 138, 143, 161, 297, 323
Tenofovir 137, 138, 144, 161, 296, 323
Tetrathiomolybdate 443, 444, 446
TMC435350 239
TMC647055 240
Transcription‐mediated 192
Transferrin receptor 2 419
Transient elastography 330
Transmission
hepatitis A virus 27
hepatitis B virus 33
hepatitis C virus 45
hepatitis E virus 58
Transplantation 349
Treatment failure 212
Treatment response 206
Trientine 443, 445
U
Ulcerative colitis 478
Ursodeoxycholic acid 465, 470, 472, 477
V
Vaccination 108
hepatitis B 111
hepatitis C 114
hepatitis E 61, 115
Valopicitabine 240, 249
Vaniprevir 239
Vascular liver disease 509
VCH222 240
VCH759 240
VCH916 240
Versant 192, 194
Victrelis 244
Viread 137
Virologic response 136
Virology
HDV 175
hepatitis B 65
hepatitis C 85
Vitamin E 446
W
Weight loss 263
Wilson’s Disease 437
Z
Zeffix 137
Zinc 445
Zinc acetate 444
No comments:
Post a Comment